Focused clinical development program with two flagship products formulated and registered under MDD.
More products are developed, formulated, and ready for further research and clinical trials.
Our Product pipeline is focused on therapeutic areas where we believe we have the best opportunity to deliver high quality
treatment and care with the use of cannabinoids.
We believe that there is a higher standard – making sure that products aren’t just lab tested, but tested under the Pharmaceutical legislations by trusted labs.
All rights reserved 2020.